The distribution of radioactivity in pregnant rats after repeated oral doses of the diuretic agent Etozolin
- PMID: 578769
The distribution of radioactivity in pregnant rats after repeated oral doses of the diuretic agent Etozolin
Abstract
1. The distribution of radioactivity has been studied by whole-body autoradiography after administration of daily oral doses of (2-14C)-ethyl (Z)-(3-methyl-4-oxo-5-piperidino-thiazolidin-2-ylidene)acetate (etozolin, Gö 687, Elkapin) at a dose level of 100mg/kg to pregnant rats during the 10th to the 17th day of gestation. 2. After the last dose, most of the radioactivity was excreted rapidly and was mainly assoicated with the gastrointestinal and urinary tracts and kidneys of the mothers. 3. Maximal distribution in the mothers occurred at 3--6 h after the last dose, and radioactivity at these times was detectable also in the lungs, muscle mass, fat, mammary and uterine tissue, the reticuloendothelial system, placentae, some ducted and endocrine glands, and in blood, but not in brain or spinal cord. At 4 days, traces of radioactivity had persisted in kidneys, liver, lungs, thyroid and placentae. 4. Radioactivity was present in low and uniform concentrations in most foetal tissues such as the heart, lungs and lens and in even lower concentrations in the brains of the foetuses during 3--6 h after dosing, but was not detected in foetal tissues at 2 days. Concentrations of radioactivity in maternal tissues were at all times much higher compared with those in foetal tissues at corresponding times after dosing.
Similar articles
-
Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.Arzneimittelforschung. 1997 Aug;47(8):939-48. Arzneimittelforschung. 1997. PMID: 9296280
-
Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.Arzneimittelforschung. 1996 Feb;46(2):114-27. Arzneimittelforschung. 1996. PMID: 8720299
-
Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.Arzneimittelforschung. 1986 Oct;36(10):1503-10. Arzneimittelforschung. 1986. PMID: 3101707
-
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.Arzneimittelforschung. 1997 Feb;47(2):201-8. Arzneimittelforschung. 1997. PMID: 9079241
-
Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.Arzneimittelforschung. 1997 Mar;47(3):285-92. Arzneimittelforschung. 1997. PMID: 9105547
Cited by
-
The disposition of SK&F L-94901, a selective thyromimetic in rat, dog and cynomolgus monkey.Eur J Drug Metab Pharmacokinet. 1989 Jul-Sep;14(3):209-19. doi: 10.1007/BF03190101. Eur J Drug Metab Pharmacokinet. 1989. PMID: 2612518
-
Placental transfer of etozolin and ozolinone during the first half of gestation in man.Eur J Clin Pharmacol. 1982;23(3):253-60. doi: 10.1007/BF00547564. Eur J Clin Pharmacol. 1982. PMID: 7173295